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Background: Tigecycline resistance in Acinetobacter baumannii is primarily acquired through overexpression of the
AdeABC efflux pump. Besides AdeRS, other two-component regulatory systems (TCSs) involving the regulation of
this transporter have not been clarified.
Results: In this study, we found that the TCS genes baeR and baeS are co-transcribed and function as stress
responders under high osmotic conditions. The baeSR and adeAB genes showed increased transcription in both the
laboratory-induced and clinical tigecycline-resistant strains compared with the wild-type strain. The deletion of baeR
in the ATCC 17978 strain led to 67–73% and 68% reduction in adeA and adeB expression, respectively, with a resultant
2-fold decrease in the tigecycline minimal inhibition concentration (MIC). In contrast, the overexpression of baeR
resulted in a doubled tigecycline MIC, with a more than 2-fold increase in adeA and adeB expression. The influence
of baeR knockout on adeAB gene expression can also be observed in the laboratory-induced tigecycline-resistant
strain. A time-kill assay showed that the baeR deletion mutant showed an approximate 1-log10 reduction in colony
forming units (CFUs) relative to the wild-type strain when the tigecycline concentration was 0.25 μg/mL throughout
the assay period. The wild-type phenotype could be restored by trans-complementation with pWH1266-kanr-baeR.
Increasing the tigecycline concentration to 0.5 μg/mL produced an even more marked 4.7-log10 reduction in CFUs
of the baeR deletion mutant at 8 h, while only a 2.1-log10 reduction was observed for the wild-type strain.
Conclusions: Taken together, these data show for the first time that the BaeSR TCS influences the tigecycline
susceptibility of A. baumannii through the positive regulation of the resistance-nodulation-division efflux pump
genes adeA and adeB.
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Acinetobacter baumannii has emerged as a major cause of
nosocomial infections, especially in intensive care units
[1]. Both its ability to acquire resistant determinants and
to adapt to harsh environments has made A. baumannii a
successful pathogen [2]. A. baumannii has high rates of
resistance to many available antibiotics in clinical practice.* Correspondence: cylan@life.nthu.edu.tw
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unless otherwise stated.For example, imipenem-resistant A. baumannii consti-
tuted > 50% of a worldwide collection of clinical samples
between 2005 and 2009 [3]. A Taiwanese surveillance re-
port of antimicrobial resistance in 2000 found that 73% of
A. baumannii isolates collected from 21 medical centers
and regional hospitals were ceftazidime-resistant [4].
Therefore, there are only a few effective anti-Acinetobacter
drugs currently available, including polymyxins and
tigecycline [5]. Tigecycline is the first drug from the gly-
cylcycline class, a new class of antibiotics derived from
tetracycline [6]. Tigecycline acts as a protein synthesis in-
hibitor by binding to the 30S ribosomal subunit, and thus. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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during translation. Although tigecycline has an expanded
spectrum of antibacterial activity, previous studies have
shown that tigecycline resistance has emerged in A.
baumannii. Resistance in these strains is associated
with multidrug efflux systems, especially the overexpres-
sion of the adeABC genes, which encode an efflux pump
[7,8]. The AdeABC pump belongs to the resistance-
nodulation-division (RND) family, which has a three-
component structure [9].
Bacterial two-component systems (TCSs) play an im-
portant role in the regulation of adaptation to and sig-
nal transduction of environmental stimuli, including
stress conditions [10]. TCSs are typically composed of a
membrane-localized sensor with histidine kinase activity
and a cytoplasmic response regulator (RR). Generally,
upon sensing environmental changes, signaling begins via
autophosphorylation of the sensor protein at a conserved
histidine residue. The phosphate is then transferred to an
aspartic acid residue in the so-called receiver domain of
the corresponding RR. Phosphorylation may induce con-
formational changes in RRs, which alters their DNA-
binding properties, thus modulating downstream gene
expression [11]. Importantly, the roles of TCSs in the
regulation of antimicrobial resistance have recently been
documented in several species of bacteria [12-14]. Add-
itionally, the AdeS-AdeR TCS controls genes encoding
the AdeABC pump in A. baumannii [15]. AdeS is a sensor
kinase, whereas AdeR is an RR. Point mutations in AdeS
and AdeR, or a truncation of AdeS due to an ISAba1 in-
sertion, may be related to the overexpression of AdeABC,
which leads to multidrug resistance [15,16]. However, the
existence of adeABC-overexpressing mutants without any
mutations in adeRS [7] and the low expression of adeABC
in a clinical strain of A. baumannii with the ISAbaI inser-
tion in the adeRS operon [16] suggest that the regulation
of adeABC gene expression is complicated, and other
regulatory mechanisms may be involved.
BaeSR is a TCS and is one of the five extracytoplasmic
response pathways in Escherichia coli. BaeSR detects en-
vironmental signals and responds by altering the bacterial
envelope [17]. The main function of the Bae response is to
upregulate efflux pump expression in response to specific
envelope-damaging agents [18]. Indole, flavonoids, and so-
dium tungstate have been shown to be novel inducers of
the BaeSR response [18,19]. In Salmonella typhimurium,
one of the physiological roles of BaeR is to respond to
stresses that specifically damage MdtA, leading to an in-
duction of MdtA transport and the removal of the toxic
agent (e.g., tungstate waste) from the cell [19]. In TolC
mutants or efflux mutants of E. coli, the overexpression of
spy, which encodes a periplasmic chaperone, depends on
the BaeRS and CpxARP stress response systems [20]. A
genome-wide analysis of E. coli gene expression showedthat BaeR overproduction activates genes involved in mul-
tidrug transport, flagellum biosynthesis, chemotaxis, and
maltose transport [21]. Furthermore, BaeSR is also able to
activate the transcription of the yegMNOB (mdtABCD)
transporter gene cluster in E. coli and increases its resist-
ance to novobiocin and deoxycholate [22]. Because there
is a potential similarity in the biological functions of
mdtABCD in E. coli and adeABC in A. baumannii, we
here explore the role of BaeSR in the regulation of the
transporter gene adeAB in A. baumannii and report the
positive regulation of these factors, which leads to in-
creased tigecycline resistance.
Results
Sequence analysis of the AdeAB efflux pump and the
BaeR/BaeS TCS
A search of the GenBank database (http://www.ncbi.nlm.
nih.gov/genbank) revealed that, similar to other strains of
A. baumannii, the ATCC 17978 strain contains sequences
encoding the AdeABC-type RND efflux pump. There are
two adeA genes (A1S_1751 and A1S_1752) and one adeB
gene (A1S_1750) in the genome; however, no adeC gene
was found. AdeB is a transmembrane component with
two conserved domains: the hydrophobe/amphiphile efflux-1
(HAE1) family signature and a domain conserved within
the protein export membrane protein SecD_SecF. Both
AdeA proteins are inner membrane fusion proteins
with biotin-lipoyl-like conserved domains. We desig-
nated A1S_1751 as AdeA1 and A1S_1752 as AdeA2
for differentiation.
The A. baumannii ATCC 17978 gene A1S_2883
encoded a protein of 228 amino acids. Sequence align-
ments of A. baumannii A1S_2883 with BaeR homologs in
other bacteria showed that A1S_2883 shared 64.6% simi-
larity with BaeR of E. coli str. K-12 substr. MG1655 and
65.2% similarity with BaeR of Salmonella enterica subsp.
enterica serovar Typhimurium str. LT2 (Figure 1A). In
addition, protein analysis using Prosite (http://prosite.
expasy.org/) predicted that A. baumannii A1S_2883 con-
tained a response regulatory domain at amino acid resi-
dues 3 to 115 and a phosphorylation site at amino acid
residue 51 (aspartate). Therefore, the role of A1S_2883
may be similar to that of BaeR in other bacterial species;
thus, we have designated A1S_2883 as BaeR in A.
baumannii.
A. baumannii ATCC 17978 gene A1S_2884 encodes a
protein of 487 amino acids. Sequence alignments showed
that A1S_2884 shared 48.1% similarity with BaeS of E. coli
str. K-12 substr. MG1655 and 46.3% similarity with BaeS
of Salmonella enterica subsp. enterica serovar Typhimur-
ium str. LT2 (Figure 1B). Protein analysis using Prosite
predicted that A. baumannii A1S_2884 contains a HAMP
(histidine kinase, adenylyl cyclase, methyl-accepting pro-
tein, and phosphatase) and a histidine kinase domain at
Figure 1 Sequence alignment of BaeR and BaeS from Acinetobacter baumannii ATCC 17978 and other bacteria. (A) Sequence alignments
of A. baumannii A1S_2883 with BaeR homologs in other bacteria revealed that A1S_2883 shares 64.6% similarity with BaeR of Escherichia coli and
65.2% similarity with BaeR of Salmonella LT2. (B) A1S_2884 shares 48.1% similarity with BaeS of E. coli and 46.3% similarity with BaeS of Salmonella
LT2. REC and trans_reg_C are two conserved domains of BaeR, while HAMP, HisKA, and HATPase_c are conserved domains of BaeS. AB17978:
A. baumannii ATCC 17978, ABAYE: A. baumannii AYE, E. coli: E. coli str. K-12 substr. MG1655, SalmonellaLT2: Salmonella enterica subsp. enterica serovar
Typhimurium str. LT2.
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ively. In addition, the histidine at residue 277 is pre-
dicted to be a phosphorylation site. Therefore, the role
of A1S_2884 may be similar to that of BaeS in other
bacterial species; thus, A1S_2884 is designated as BaeS
in A. baumannii.
Co-transcription of baeR and baeS as an operon
Although the BaeSR TCS has been characterized in E.
coli [21,22], the biological functions of BaeSR in A. bau-
mannii have not been revealed. Genome analysis of A.
baumannii ATCC 17978 shows that the coding se-
quences of baeR (A1S_2883) and baeS (A1S_2884) arearranged sequentially, suggesting that the two genes may
be co-transcribed as an operon. To test this hypothesis,
reverse transcription-polymerase chain reaction (RT-PCR)
was performed using the primers baeS-co F and baeS-co R
(Table 1). As shown in Figure 2A, a 793-bp DNA fragment
covering the junction between both baeR and baeS was
amplified by RT-PCR. We concluded that baeR and baeS
are co-transcribed as a single operon in A. baumannii
ATCC 17978.
Transcription of baeR and baeS under normal and
stressed conditions
TCSs are commonly involved in stress responses in bac-
teria. Because no previous studies have explored the
Table 1 Oligonucleotides used in this study























16 s rRNA_F GTAGCTTGCTACTGGACCTAG

















aRestriction sites introduced into the primers are highlighted using bold fonts
and described in the primer name.
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ing the response of both genes to high osmotic condi-
tions to determine if they have functions that are similar
to those of their BaeSR counterparts in other bacteria.
To determine whether A. baumannii baeSR participates
in the stress response, the relative levels of baeR and
baeS transcription were detected in cells grown in Luria-
Bertani (LB) agar (37°C, 220 rpm) with or without 20%
sucrose. RT-PCR analysis showed that the expression
levels of baeR and baeS were 2.3- and 6.7-fold higher in
cells exposed to osmotic stress compared with cells
grown without sucrose (Figure 2B). This result suggested
that the BaeSR TCS in A. baumannii was involved in
cellular adaptation to stress conditions such as high
osmolarity.Construction of baeR deletion mutants and baeR-
reconstituted strains
To further study the role of the BaeSR TCS in A. bau-
mannii, in-frame deletion mutants of baeR were gener-
ated using the method of Sugawara et al. [23]. The
successful construction of baeR deletion mutants was
verified by PCR (Additional file 1: Figure S1B), RT-PCR
(Additional file 2: Figure S2), and Southern blot assays
(Additional file 3: Figure S3B). To generate the baeR-
reconstituted strain, pWH1266-kanr-baeR was intro-
duced into the baeR deletion mutant (AB1026; Table 2)
by electroporation. The baeR-reconstituted strain was
designated AB1027. In addition, pWH1266-kanr-baeR
was also introduced into the wild-type strain to generate
the strain AB1028. Successful construction of the
AB1027 and AB1028 strains was verified by RT-PCR.
The expression of baeR was comparable in the wild-type
and the baeR-reconstituted AB1027 strains, whereas baeR
was overexpressed in AB1028 relative to the wild-type
strain (data not shown).Minimal inhibitory concentration (MIC) determination
To correlate BaeR with tigecycline susceptibility, the
MIC of tigecycline was determined. For A. baumannii
ATCC 17978, the MIC of tigecycline was 0.5 μg/mL.
However, the MIC of tigecycline for the baeR deletion
mutant was 0.25 μg/mL; baeR reconstitution restored
the MIC to the wild-type level (MIC 0.5 μg/mL). Moreover,
the overexpression of baeR in AB1028 raised the MIC of
tigecycline to 1 μg/mL. The introduction of pWH1266
alone did not affect the MIC of tigecycline, whereas the
MICs obtained with the induced tigecycline-resistant strain
ABtc and the clinical tigecycline-resistant strain ABhl1
were 256 and 16 μg/mL, respectively. These results indi-
cate that BaeR is closely related to the tigecycline suscepti-
bility of A. baumannii.
Figure 2 Evaluation of baeR and baeS expression. (A) The co-transcription of baeR and baeS was determined by agarose gel electrophoresis
of the product obtained by reverse transcription polymerase chain reaction (RT-PCR). Lane 2 (cDNA) and 3 (genomic DNA) reveal a 793-bp DNA
fragment covering the junction between both the baeR and baeS genes. (B) The relative transcript levels of baeR and baeS, as determined by
RT-PCR, under different osmolarity conditions. The cells were grown on Luria-Bertani (LB) agar with or without 20% sucrose (37°C, 220 rpm).
16S rRNA and rpoB genes were used as controls. The expression levels of baeR and baeS were 2.3- and 6.7-fold higher in cells experiencing
osmotic stress than those in cells grown without sucrose. The results are displayed as the means ± SD from four independent experiments.
*, P < 0.05; **, P < 0.01.
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different levels of tigecycline resistance
To further decipher the role of the BaeSR TCS and
AdeAB in tigecycline resistance, we analyzed gene expres-
sion in the wild-type A. baumannii strain ATCC 17978 as
well as the ABtc and ABhl1 strains. The quantitative real-
time PCR (qRT-PCR) results showed that the expression
levels of adeB were 216- and 53-fold higher in ABtc and
ABhl1, respectively, than in the wild-type strain. ABtc andTable 2 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant feature
A. baumannii strains ATCC 17978 Wild-type strain
AB1026 (ΔbaeR::kanr) Derived from ATC
gene replacemen
AB1027 AB1026 baeR::pWH
AB1028 ATCC 17978 baeR
AB1029 ATCC 17978 kan::
ABtc Induced tigecyclin
ABtcm (ΔbaeR::kanr) Derived from ABtc
replacement
ABhl1 Tigecycline resista
E. coli strains XL1 blue recA1 endA1 gyrA9
lacIqZΔM15 Tn10
S17-1 (ATCC 47055) thi pro hsdR hsdM
Plasmids pEX18Tc Suicide vector con
pSFS2A Containing kanr, an
pEX18Tc-Δbae::kanr pEX18Tc containin
fragments joined
pWH1266 (ATCC 77092) E. coli-A. baumanni
pC2HP Provided kanr for
pWH1266-kanr pWH1266 contain
pWH1266-kanr-baeR pWH1266-kanr coABhl1 also showed increased transcription of adeA1
and adeA2, although it was less marked than that of adeB
(Figure 3A). The expression levels of baeS and baeR in
ABtc increased 3.19 and 2.64-fold, respectively, compared
with the wild-type strain, whereas those in ABhl1 only in-
creased 1.93 and 1.39-fold, respectively (Figure 3B). Over-
all, the combination of the qRT-PCR results with the MIC
assay above suggest that both BaeSR and AdeAB are in-
volved in the tigecycline resistance of A. baumannii.(s) Source or reference
ATCC






e resistant ATCC 17978 This study
. baeR mutant obtained by kanr gene This study
nt clinical isolate This study
6 thi-1 hsdR17 supE44 relA1 lac [F’ proAB
(Tetr)]
Stratagene
recA[RP42-Tc::Mu- Km::Tn7 (TprSmr)Tra+] ATCC
taining sacB, Tcr 40
FRT site, FLP1, and CaSAT1 as a SAT1 flipper 41
g baeR upstream and downstream
by a kanr cassette
This study
i shuttle cloning vector, containing Ampr, Tetr 43
pWH1266 42
ing kanr This study
ntaining baeR This study
Figure 3 Transcript levels of the adeA, adeB, baeR, and baeS
genes in A. baumannii strains. ABtc and ABhl1 are laboratory-induced
and clinically isolated tigecycline-resistant strains, respectively. The
corresponding tigecycline minimum inhibitory concentrations (MICs) of
ATCC 17978, ABtc, and ABhl1 were 0.5, 256, and 16 μg/mL, respectively.
Gene expression was detected by quantitative real-time PCR (qRT-PCR).
(A) qRT-PCR showed that the expression levels of adeB in ABtc and
ABhl1 were 216- and 53-fold higher than those in the wild-type
strain, respectively. The adeA1 expression levels in ABtc and ABhl1
were 99- and 22-fold higher than those in the wild-type strain,
respectively, whereas the adeA2 expression levels in ABtc and ABhl1
were 134- and 25-fold higher. (B) The expression levels of baeS and
baeR in ABtc increased 3.19 and 2.64 times, respectively, compared
with the wild-type strain, whereas those in ABhl1 only increased
1.93 and 1.39 times, respectively. 16S rRNA gene was used as a
control. The results are displayed as the means ± SD from four
independent experiments. *, P < 0.05; **, P < 0.01.
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expression
To understand whether baeR influenced the tigecycline
MIC by affecting the adeAB efflux pump gene, the ex-
pression of adeA1, adeA2, and adeB in ATCC 17978,
AB1026, AB1027, and AB1028 was analyzed by qRT-
PCR. The expression levels of adeB, adeA1, and adeA2
in AB1028 were approximately 2.9-, 2.1-, and 3-fold
higher, respectively, than those in ATCC 17978, while
the deletion of baeR from the wild-type strain decreased
the expression levels of these three pump genes by
68.3%, 67.3%, and 73.5%, respectively (Figure 4A). The
decreased expression of the pump genes can be partially
restored by baeR reconstitution (Figure 4A). To deter-
mine the impact of baeR deletion on adeR expression,
RT-PCR was also performed. No differences in adeR ex-
pression were observed between AB1026 and the wild-type strain (data not shown). Overall, these findings sug-
gest that BaeR upregulates the expression of adeAB
genes.
Expression analysis of adeAB in induced tigecycline-
resistant A. baumannii and its baeR mutant
To further confirm the role of baeR in the tigecycline re-
sistance of A. baumannii via the AdeAB efflux pump, a
baeR deletion mutant of ABtc (ABtcm) was constructed
and adeAB expression was analyzed by qRT-PCR. The
expression levels of adeB, adeA1, and adeA2 in ABtcm
were 51.5, 42.7%, and 43.7% lower, respectively, than
those in ABtc (Figure 4B). These data confirmed the
contribution of BaeR to the regulation of AdeAB, which
is essential to tigecycline resistance in A. baumannii.
Time-kill assay
To further compare the effects of BaeR on tigecycline sus-
ceptibility, time-kill assays were performed using ATCC
17978, AB1026, AB1027, and AB1028. There were no dif-
ferences in the surviving colony forming units (CFUs)
among these four strains when tigecycline was not added
to the LB agar. In the presence of 0.25 μg/mL tigecycline,
all tested strains had similar surviving CFU curves; the
lowest value was observed at 4 h, which was followed
by regrowth (Figure 5A). Additionally, AB1026 showed
a greater reduction in CFUs than the wild-type strain
(e.g., 2.9-log10 versus 1.8-log10 reduction, respectively, at
4 h) throughout the assay period, which could be restored
by baeR reconstitution. Increasing the tigecycline concen-
tration to 0.5 μg/mL produced an even more marked 4.7-
log10 reduction in the CFUs of AB1026 at 8 h, which was
followed by regrowth. In contrast, a smaller reduction
(2.1-log10 reduction at 8 h) was observed for the wild-type
strain (Figure 5B). However, baeR reconstitution did not
fully restore the ability of AB1026 to resist 0.5 μg/mL tige-
cycline. AB1028 showed a slightly smaller reduction in
CFUs than the wild-type strain in the presence of 0.25 and
0.5 μg/mL tigecycline. Therefore, the time-kill assay indi-
cates that the BaeSR TCS plays a role in the tigecycline
susceptibility of A. baumannii.
Discussion
Previous studies that investigated the regulation of
AdeABC efflux pumps in A. baumannii primarily fo-
cused on the AdeRS TCS, which is located upstream of
the adeABC operon and is transcribed in the opposite
direction [15]. Several point mutations in adeR or adeS
have been proposed as the major cause of AdeABC efflux
pump overexpression, including a threonine-to-methionine
substitution at position 153 [15], a glycine-to-aspartate mu-
tation at position 30 [24], an alanine-to-valine substitution
at position 94 of AdeS [25], or a proline-to-leucine substitu-
tion at position 116 of AdeR [15]. However, the effect of
Figure 4 Transcript levels of the adeA and adeB genes in different strains of A. baumannii. AB1026, AB1027, and AB1028 are the baeR
deletion mutant, baeR reconstitution, and wild-type with baeR overexpression strains, respectively. ABTcm is the baeR deletion mutant of ABtc,
which was a laboratory-induced tigecycline-resistant strain. The relative expression of adeB, adeA1, and adeA2 was determined by qRT-PCR.
(A) The expression levels of adeB, adeA1, and adeA2 in AB1028 were approximately 2.9-, 2.1-, and 3-fold higher, respectively, than those in ATCC
17978, while the deletion of baeR in the wild-type strain decreased the expression levels of these three pump genes by 68.3%, 67.3%, and 73.5%,
respectively. The decreased expression of the pump genes can be partially restored by baeR reconstitution. (B) The expression levels of adeB,
adeA1, and adeA2 in ABtcm were 51.5%, 42.7%, and 43.7% lower, respectively, than those in ABtc. 16S rRNA gene was used as a control. The
results are displayed as the means ± SD from three independent experiments. *, P < 0.05; ***, P < 0.001. #, P < 0.05 between ABtc and ABtcm.
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not always consistent. Different tigecycline MICs were ob-
served in two transformed strains with the same muta-
tions in the DNA-binding domain of the AdeR protein
[16]. adeABC-overexpressing mutants that did not carry
any mutations in adeRS compared with their isogenic
parents were also reported [7,25]. Another mechanism
leading to the overexpression of AdeABC involves the
transposition of an ISAba1 copy into adeS [15], which
stimulates AdeR to interact with and activate the adeABC
promoter [16]. In contrast to the results of the above-
mentioned studies of AdeRS, four imipenem-resistant A.
baumannii strains carrying adeB but lacking adeRS were
identified by Hou et al. [26], suggesting that another regu-
latory mechanism may be involved. Henry et al. reported
that BaeSR was associated with the increased expression
of the multidrug resistance-associated efflux pump genes
macAB-tolC and adeIJK in their transcriptional analysis oflipopolysaccharide-deficient A. baumannii 19606R [27].
Therefore, the role of BaeSR in the expression of the
AdeABC efflux pump deserves investigation. Our data
demonstrate that BaeSR influences the tigecycline suscep-
tibility of A. baumannii ATCC 17978 through its positive
regulation of the transcription of transporter genes adeA
and adeB. This result supported the possibility that other
TCSs aside from AdeRS may be involved in the regulation
of the AdeABC efflux pump in A. baumannii.
Most A. baumannii strains have an RND efflux pump,
AdeABC, which has a three-component structure with
AdeB forming the transmembrane component, AdeA
forming the inner membrane fusion protein, and AdeC
forming the outer membrane protein [9]. However, accord-
ing to the NCBI GenBank database, A. baumannii ATCC
17978 lacks an adeC gene but has two adeA genes and one
adeB gene. A. baumannii AYE, A. baumannii ACICU, A.
baumannii ATCC 19606, and A. baumannii TYTH-1 all
Figure 5 Time-kill assays for ATCC 17978, AB1026, AB1027, and AB1028 with 0.25 μg/mL (A) and 0.5 μg/mL (B) tigecycline. In the
presence of 0.25 μg/mL tigecycline, all tested strains showed similar surviving colony forming unit (CFU) curves, in which the lowest value
occurred at 4 h and was followed by regrowth. AB1026 had a greater CFU reduction than the wild-type strain throughout the assay period, which
could be restored by baeR reconstitution. Increasing the tigecycline concentration to 0.5 μg/mL resulted in a marked 4.7-log10 CFU reduction for
AB1026 at 8 h, which was followed by regrowth, whereas a smaller reduction was observed for the wild-type strain. baeR reconstitution did not
fully restore the ability of AB1026 to resist 0.5 μg/mL tigecycline. AB1028 had a slight, though not significant, CFU reduction compared to the
wild-type strain in the presence of 0.25 or 0.5 μg/mL tigecycline. Viable counts represented by CFUs were determined at time 0 and at 4, 8, 12,
and 16 h after inoculation. A time-kill curve was constructed for each strain. The results are displayed as the means ± SD from three independent
experiments. *, P < 0.05.
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et al. constructed a clinical A. baumannii strain with an
inactivated adeC. This derivative mutant displayed resist-
ance to the various substrates of the AdeABC pump that
was similar to that of the wild-type strain, indicating that
adeC is not essential for resistance [15]. Because adeC was
not found in 41% of the clinical isolates carrying adeRS-
adeAB in one study [28], it is reasonable to deduce that
AdeAB could recruit another outer membrane protein to
form a functional tripartite complex [29].
The first description of tigecycline non-susceptibility
was reported by Peleg et al. [7]. These authors found that
the efflux pump inhibitor phenyl-arginine-β-naphthyla-
mide could cause a four-fold reduction in the MIC of tige-
cycline in two tigecycline-non-susceptible isolates. The
qRT-PCR results showed 40-fold and 54-fold increases inadeB expression in these two isolates compared to that
observed in a tigecycline-susceptible isolate. Their finding
is consistent with our comparison of tigecycline MICs and
expression levels of AdeAB among the wild-type, ABhl1,
and ABtc strains. Despite the important role of AdeABC
in antibiotic resistance, this efflux pump operon is cryptic
in natural isolates of A. baumannii [15,30]. Antibiotic
exposure, including exposure to tigecycline, could in-
duce pump overexpression, resulting in drug resistance
[29]; this was observed in our ABtc strain. Furthermore,
there was a statistically significant linear relationship
between log-transformed adeA expression values and
log-transformed MICs of tigecycline in clinical isolates
of the A. calcoaceticus-A. baumannii complex, indicating
that the overexpression of the AdeABC efflux pump is a
prevalent mechanism for this resistance phenotype [31].
Lin et al. BMC Microbiology 2014, 14:119 Page 9 of 12
http://www.biomedcentral.com/1471-2180/14/119The modest increase in AdeAB pump gene expression
in AB1028 relative to the wild-type strain may have been
due to the overexpression of BaeSR. However, because
ABtcm had only moderately reduced adeB, adeA1, and
adeA2 expression levels relative to ABtc, we proposed
that control mechanisms aside from BaeSR, such as se-
quence changes in adeR or adeS, were responsible for the
overexpression of these pump genes. The regulators that
are involved in efflux gene expression are either local or
global regulators [32]. One of the most well-studied exam-
ples is the AcrAB-TolC system of E. coli [33]. This system
is under the control of the local repressor gene acrR,
which negatively regulates the transcription of acrAB. On
the other hand, global stress conditions are assumed to re-
sult in the generation of global transcription regulators.
These regulators are unlikely to be MarA, SoxS, or Rob,
but could be their homologs. Such regulators increase the
transcription of not only acrAB but also acrR, which func-
tions as a secondary modulator to repress acrAB. Fer-
nando et al. demonstrated that the transcription patterns
of both adeB and adeJ are cell density-dependent and
similar, indicating a role for global regulatory mechanisms
in the expression of these genes in A. baumannii [34].
Two-component regulatory systems mediate the adaptive
responses of bacterial cells to a broad range of environ-
mental stimuli [35]. In this study, qRT-PCR analysis of
baeSR expression under high sucrose conditions suggested
that this TCS was involved in the regulation related to this
stress condition. Therefore, we propose that BaeSR, which
functions as an envelope stress response system to exter-
nal stimuli, also influences the transcription of adeAB in
A. baumannii by functioning as a regulator of global tran-
scription. Meanwhile, the well-described adeR is an
example of a local regulator that activates adeABC expres-
sion [15,16]. However, the relationship between BaeSR
and AdeRS must be further clarified. Because the expres-
sion of adeRS was only marginally increased in the baeSR
deletion mutants in this study, we assume that the cross-
talk between these TCSs might be absent or only very
weak. The question of whether other TCSs are involved in
the regulation of the AdeABC efflux pump and how they
interact in A. baumannii merits further investigation.Conclusions
In this study, we showed for the first time that the BaeSR
TCS influences the tigecycline susceptibility of A. bau-
mannii by positively regulating the RND efflux pump
genes adeA and adeB. However, whether BaeSR can also
contribute to tigecycline resistance through other trans-
porter genes, such as macAB-tolC and adeIJK, is not yet
clear, and related studies are underway. Overall, this find-
ing highlights the complexity of AdeABC transporter
regulation and could be a starting point for understandingthe role of TCSs in the antimicrobial susceptibility of
bacteria.
Methods
Bacterial strains, plasmids, growth conditions, and
antibiotic susceptibility testing
The bacterial strains and plasmids used in this study are
listed in Table 2. The cells were grown at 37°C in LB broth
and agar. To determine the MIC, a broth microdilution
method was used according to the 2012 CLSI guidelines
[36]. Briefly, bacteria were inoculated into 1 mL cation-
adjusted Mueller-Hinton broth (CAMHB) (Sigma-Aldrich,
St. Louis, MO) containing different concentrations of tige-
cycline (Pfizer, Collegeville, PA) to reach ≈ 5 × 105 CFU/mL,
and the cultures were incubated at 37°C for 24 h. The low-
est tigecycline concentration that completely inhibited
bacterial growth was defined as the MIC, and growth was
determined by unaided eyes and by measuring optical
densities (ODs) using a spectrophotometer. On the basis
of the report published by Pachón-Ibáñez et al., the
provisional MIC breakpoints for tigecycline are ≤2, 4,
and ≥8 μg/mL to designate susceptible, intermediate,
and resistant strains, respectively [37].
DNA manipulation
Plasmid DNA was prepared with the FavorPrep™ Plasmid
DNA Extraction Mini Kit (Favorgen, Ping-Tung, Taiwan).
A. baumannii genomic DNA was extracted as described
previously [38]. PCR amplification of the DNA was per-
formed in a Thermo Hybaid PXE 0.2 HBPX02 Thermal
Cycler (Thermo Scientific, Redwood, CA), using ProTaq™
DNA Polymerase (Protech, Taipei, Taiwan) or the KAPA
HiFi™ PCR Kit (Kapa Biosystems, Boston, MA). DNA
fragments were extracted from agarose gels and purified
using the GeneKlean Gel Recovery & PCR CleanUp Kit
(MDBio, Inc., Taipei, Taiwan). Nucleotide sequences of the
PCR products were verified using an ABI 3730XL DNA
Analyzer (Applied Biosystems, South San Francisco, CA).
RNA isolation, RT-PCR, and qRT-PCR
For total RNA isolation, A. baumannii ATCC 17978 was
grown overnight in LB broth (37°C, 220 rpm, 16 h) to
reach an OD600 of approximately 6.5. The overnight cul-
tures were sub-cultured at a 1:100 dilution in 25 mL
fresh LB medium. The cells were grown to mid-log
phase and harvested by centrifugation at 4°C. The cell
pellets were resuspended in 200 μL ice-cold RNA extrac-
tion buffer (0.1 M Tris-Cl [pH 7.5], 0.1 M LiCl, 0.01 M
ethylenediaminetetraacetic acid [pH 8.0], 5% sodium do-
decyl sulfate [SDS], 2% β-mercaptoethanol), and 200 μL
ice-cold phenol-chloroform-isoamyl alcohol (PCIA [25:24:1],
pH 4.5) was added and vortexed for 2 min. The supernatants
were then collected by centrifugation, added to 200 μL
ice-cold PCIA, and mixed well. This step was repeated
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at −80°C overnight and collected by centrifugation at
maximum speed for 5 min. The RNA pellets were dis-
solved in 25–100 μL diethylpyrocarbonate-treated water.
DNA was removed using Ambion® TURBO™ DNase (Life
Technologies, Grand Island, NY), and cDNA was synthe-
sized by reverse transcription using High-Capacity cDNA
Reverse Transcriptase Kits (Applied Biosystems). The
cDNAs were used in PCR reactions with different primers
(Table 1).
qRT-PCR was carried out with a StepOne™ Real-Time
PCR System (Life Technologies). The primers used for
qRT-PCR are listed in Table 1. Briefly, each 20-μL reac-
tion mixture contained 25 ng cDNA, 10 μL Power SYBR
green PCR master mix (Life Technologies), and 300 nM
each forward and reverse primer. The reactions were
performed with 1 cycle at 95°C for 10 min followed by
40 cycles of 95°C for 15 s and 60°C for 1 min. The 16S
rRNA transcript was used as an endogenous control for
the qRT-PCR. The data were analyzed using StepOne
v2.1 software (Life Technologies).
Induction of tigecycline resistance
To induce tigecycline resistance, serial passaging was
performed as previously described [39] with some modi-
fications. Briefly, on day 1, 3 mL of LB broth containing
tigecycline at the MIC was inoculated with A. bauman-
nii (passage 1), and the cultures were incubated at 37°C
with shaking (220 rpm). On day 3, 30 μL of the culture
was transferred to 3 mL of LB broth containing tigecyc-
line at 8× the MIC (passage 2), and the cultures were
again incubated at 37°C with shaking (220 rpm). On day
5, 30 μL of the culture was transferred into LB broth
containing tigecycline at 16× the MIC (passage 3), and
the cultures were again incubated at 37°C with shaking
(220 rpm). This passaging was repeated on day 7 (pas-
sage 4). On day 9, aliquots (3 mL) of the cultures were
mixed with 10% glycerol and stored at −80°C until use.
Daily passaging in tigecycline-free LB was conducted for
30 days for both ATCC 17978 and the clinical strain.
Construction of baeR deletion mutants and baeR
reconstituted strains
To assess the contribution of BaeR to the regulation of
tigecycline resistance, baeR deletion mutants of A. bau-
mannii ATCC 17978 were constructed as previously de-
scribed [23] with some modifications. The suicide vector
pEX18Tc [40] was first cloned with a 953-bp DNA frag-
ment carrying a kanamycin resistance cassette, which
was PCR-amplified from the pSFS2A plasmid [41], to
generate pEX18Tc-kanr. DNA fragments carrying the
upstream and downstream regions of the baeR gene, re-
ferred to as baeR-up and baeR-dw, were independently
amplified by PCR using the primer pairs baeR-up-SalI-Fand baeR-up-BamHI-R or baeR-dw-KpnI-F and baeR-
dw-SacI-R (Table 1). The baeR-up fragment (1,119 bp)
was digested with SalI and BamHI enzymes, whereas
the baeR-dw fragment (1,120 bp) was digested with KpnI
and SacI enzymes (Additional file 4: Figure S4A). Both
enzyme-digested DNA fragments were then independ-
ently cloned into the corresponding restriction sites of
pEX18Tc-kanr, generating pEX18Tc-kanr-baeR-flanking.
The resultant plasmid was then transformed into the E.
coli S17-1 strain using the standard CaCl2/heat shock
method [38]. Then, trans-conjugation was performed be-
tween E. coli S17-1 donor cells and A. baumannii ATCC
17978 recipient cells to transfer and integrate pEX18Tc-
kanr-baeR-flanking into the chromosome of ATCC 17978
(Additional file 4: Figure S4B). By growing the ATCC
17978 conjugate cells on LB agar containing 10% sucrose,
the cells were able to resolve the suicide plasmid pEX18Tc
(Additional file 4: Figure S4C). Sucrose-resistant colonies
were examined to verify that they had the kanamycin-
resistant phenotype as a result of plasmid eviction. The
absence of the baeR gene sequence in the genome was
verified by PCR and RT-PCR and further confirmed by
Southern blot hybridization.
To reconstitute the baeR gene in the baeR-deleted
mutants, a DNA fragment carrying the entire baeR gene
sequence was generated by PCR using the genomic
DNA of A. baumannii ATCC 17978 as the template.
Briefly, a kanamycin resistance cassette was first ampli-
fied from the pC2HP vector [42] and cloned into the
E. coli/Acinetobacter shuttle vector pWH1266 [43,44]
(Additional file 5: Figure S5A and S5B). Subsequently,
the baeR DNA fragment was cloned into the XbaI/XhoI
restriction sites (Additional file 5: Figure S5C). The plas-
mid was transformed into the wild-type strain and the
baeR deletion mutants by electroporation, thus creating
the baeR-overexpressing strain and complemented mutant
strains, respectively. The overexpression and baeR-recon-
stituted strains were selected on LB agar containing
10 μg/mL tetracycline and were further verified by PCR
(Additional file 5: Figure S5D) and RT-PCR (Additional file 2:
Figure S2).
Southern blot hybridization
Southern blot analysis was performed as reported in a
previous publication [45]. Genomic DNA was extracted,
and approximately 10 μg was digested with BclI over-
night at 50°C. The DNA was then separated on a 0.8%
agarose gel containing 1:10,000 SYBR Safe gel stain
(Invitrogen, Grand Island, NY), transferred onto a posi-
tively charged nylon membrane (Pall Corporation, Port
Washington, NY) via the alkaline transfer method [38],
and fixed by baking at 80°C for 2 h. The membrane was
hybridized with an [α-32P] dCTP-labeled baeS probe
(Additional file 3: Figure S3A) using prehybridization
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NaCl plus 0.015 M sodium citrate], 5× Denhardt’s reagent,
0.5% SDS, 100 μg/mL salmon sperm DNA, and 50%
formamide) at 42°C overnight. The membrane was then
washed and visualized by autoradiography.Time-kill assay
The time-kill assays were carried out in duplicate as pre-
viously described [46] with some modifications. Briefly,
cells were grown to log phase and sub-cultured into
10 mL CAMHB broth without (control) or with tigecyc-
line (0.25 or 0.5 μg/mL) to a cell density of approxi-
mately 5 × 105 CFU/mL. The cultures were incubated in
an ambient atmosphere at 37°C. At different time points
(0, 4, 8, 12, and 16 h) after inoculation, 0.1 mL of the
culture was removed from each tube and 10-fold serially
diluted. Then, 25 μL of each diluted cell suspension was
spotted onto LB agar in duplicate. Viable cell counts
were determined, the duplicates were averaged, and the
data were plotted.Additional files
Additional file 1: Figure S1. Verification of the baeR deletion mutants.
(A) Diagram of the baeR gene and deletion mutant verification using
appropriate primers. (B) Successful baeR gene fragment deletion was
deduced based on a change in the PCR band size from 4539 bp to
4884 bp.
Additional file 2: Figure S2. Southern blot analysis. (A) Genomic DNA
from the baeR deletion mutant and the parental strain was digested by
BclI. The location of the specific DNA probe is shown. (B) The bands
corresponding to 6.7-kb and 2.8-kb fragments are indicated. Four
independent clones of AB1026 are included.
Additional file 3: Figure S3. Construction of the baeR deletion mutant.
(A) A single crossover between pEX18Tc containing baeR upstream and
downstream sequences joined by a kanr cassette and the ATCC 17978
chromosome. (B) Two mechanisms by which the plasmid can integrate
into the chromosome are diagrammed. (C) The suicide plasmid was
excised by 10% sucrose counter-selection and selection of the in-frame
baeR deletion strain with kanamycin.
Additional file 4: Figure S4. Shuttle vector pWH1266 and verification
of pWH1266 introduction into different strains of Acinetobacter
baumannii. (A) pWH1266. (B) pWH1266 with kanamycin cassette
insertion. (C) baeR insertion into the XbaI/XhoI restriction sites in
pWH1266. (D) Successful baeR gene fragment insertion into the
kanamycin cassette was deduced based on a change in the PCR band
size from 1375 bp to 983 bp. AB1027, AB1028, and AB1029 represent the
baeR reconstituted strain, the baeR-overexpressing strain, and the A.
baumannii ATCC 17978 strain with pWH1266, respectively.
Additional file 5: Figure S5. baeR gene expression in different A.
baumannii strains as determined by reverse transcription polymerase
chain reaction. No baeR expression could be observed in AB1026. AB1027
was the baeR-reconstituted strain derived from AB1026, which had a
baeR expression level similar to that of the wild-type strain. AB1028 and
AB1029 represent the baeR-overexpressing strain and A. baumannii ATCC
17978 with pWH1266, respectively.Competing interests
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